SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-259691
Filing Date
2022-10-07
Accepted
2022-10-07 17:17:58
Documents
12
Period of Report
2022-10-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d405808d8k.htm   iXBRL 8-K 22728
  Complete submission text file 0001193125-22-259691.txt   143288

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA meip-20221004.xsd EX-101.SCH 2863
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20221004_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20221004_pre.xml EX-101.PRE 11266
6 EXTRACTED XBRL INSTANCE DOCUMENT d405808d8k_htm.xml XML 3342
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-50484 | Film No.: 221301501
SIC: 2834 Pharmaceutical Preparations